• 제목, 요약, 키워드: Thymic tumors

검색결과 31건 처리시간 0.049초

Relationship Between Computed Tomography Manifestations of Thymic Epithelial Tumors and the WHO Pathological Classification

  • Liu, Guo-Bing;Qu, Yan-Juan;Liao, Mei-Yan;Hu, Hui-Juan;Yang, Gui-Fang;Zhou, Su-Jun
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.13 no.11
    • /
    • pp.5581-5585
    • /
    • 2012
  • Objective: To explore the relationship between computed tomography (CT) manifestations of thymoma and its WHO pathological classification. Methods: One hundred and five histopathologically confirmed cases were collected for their pathological and CT characteristics and results were statistically compared between different pathological types of thymoma. Results: Tumor size, shape, necrosis or cystic change, capsule integrity, invasion to the adjacent tissue, lymphadenopathy, and the presence of pleural effusion were significantly different between different pathological types of thymomas (P<0.05). Type B2, B3 tumors and thymic carcinomas were greater in size than other types. More than 50% of type B3 tumors and thymic carcinomas had a tumor size greater than 10 cm. The shape of types A, AB, and B1 tumors were mostly round or oval, whereas 75% of type B3 tumors and 85% of thymic carcinomas were irregular in shape. Necrosis or cystic change occurred in 67% of type B3 thymomas and 57% of thymic carcinomas, respectively. The respective figures for capsule destruction were 83% and 100%. Increases in the degree of malignancy were associated with increases in the incidence of surrounding tissue invasion: 33%, 75%, and 81% in type B2, type B3, and thymic carcinomas, respectively. Pleural effusion occurred in 48% of thymic carcinomas, while calcification was observed mostly in type B thymomas. Conclusions: Different pathological types of thymic epithelial tumors have different CT manifestations. Distinctive CT features of thymomas may reflect their pathological types.

Diagnostic and Clinical Significance of KIT(CD117) Expression in Thymic Epithelial Tumors in China

  • Song, Nan;Chen, Gang;Zhang, Peng;Liu, Ming;He, Wen-Xin;Jiang, Ge-Ning
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.13 no.6
    • /
    • pp.2745-2748
    • /
    • 2012
  • Aims: To study KIT (CD117) expression in thymic epithelial tumors in China, and investigate diagnostic and clinical significance. Material and Methods: Thymic epithelial tumors (TETs) from 102 patients (3 type A, 29 type AB, 5 type B1, 22 type B2, 29 typeB3 and 16 thymic carcinomas) were examined. Immunohistochemical staining with an antic-kit monoclonal antibody was performed on a tissue microarray. Relationships between KIT positive expression and the TET clinical characteristics (WHO histologic classification and Masaoka stage system) were analysed. Results: The KIT positive expression rate was significantly higher in thymic carcinoma (60%, 9/16) than in thymoma (8%, 7/86), a strong correlation being found with the WHO classification, but not the Masaoka tumor stage. The overall survival for patients with KIT positive lesions was significantly worse. Conclusions: KIT is a good molecule marker to differentially diagnose thymic carcinoma from thymoma, while also serving as a predictor of prognosis for TETs. Further research into KIT mutations in Chinese TETs should be conducted to assess the efficacy of targeted therapy.

흉선에 발생한 종양 10례에 대한 임상적 고찰 (Clinical evaluation of thymic tumors: a report of 10 cases)

  • 곽문섭;이홍균
    • The Korean Journal of Thoracic and Cardiovascular Surgery
    • /
    • v.16 no.4
    • /
    • pp.571-583
    • /
    • 1983
  • Thymic tumor is the most common neoplasm originating in the anterior mediastinum. Histologically, thymic tumors and tumorlike conditions have been classified into thymic cyst, thymolipoma, true thymic hyperplasia, thymoma and carcinoid tumor of the thymus gland. We have experienced several tumors and a few tumorlike conditions of the thymus gland in 10 patients: thymoma 6, thymic hyperplasia 2, carcinoid tumor 1 and thymic cyst 1. The age distributions were ranging from 30 to 60 years except for one 3 year old child [malignant thymoma, lymphocytic type], and male to female ratio was 1:1.5. In 6 cases, thymic lesions were removed through lateral thoracic incision [right 2, left 4] because the mediastinal masses were growing far into the pleural space, meanwhile, medially located lesions [4 cases] through median sternotomy incision. Among these 10 patients, 3 were malignant thymomas, in which 2 were died of recurrence after tumor resection. Myasthenia gravis was all noted in 3 females [thymoma 2, thymic follicular hyperplasia 1], in which only two revealed remission in symptoms following thymectomy. The authors would like to recommend early radical thymectomy through median sternotomy incision whenever patients demonstrate suspicious thymic tumor lesions on the chest roentgenogram or generalized myasthenic symptoms.

  • PDF

Single Institution Experience of Thymic Tumor Treatment and Survival in Egypt

  • Darwish, Dalia
    • Asian Pacific Journal of Cancer Prevention
    • /
    • v.17 no.2
    • /
    • pp.771-774
    • /
    • 2016
  • Thymic tumors are the most common tumors in the anterior mediastinum. Total resection is the main treatment and predictor of longer survival. Adjuvant radiotherapy alone or in combination with chemotherapy is recommended with incomplete excision or advanced disease. Thirty seven patients with thymic tumors were included in this retrospective study from January 2001 till December 2012. They were studied regarding age, sex, performance status, tumor size and invasion, stage, pathology, treatment given, overall and progression free survival. Myasthenia gravis was present in 18.1% of the patients. Masaoka stage III was diagnosed in 40.5% of the cases followed by stage II in 24.3% and the other stages with lower percentages. Pathology type B3 was the most frequent followed by B2 and B1 with percentages of 27, 24.3 and 21.7 respectively. Complete resection was conducted in 11 cases (29.75%). Partial resection or debulking was done in 15 (40.5%) and a biopsy was taken in 11 cases (29.8%) Adjuvant chemotherapy was given to 14 patients (37.8%) and neoadjuvant to 13 (35.2%). Adjuvant radiotherapy was given to 17 patients (46%) and neoadjuvant to 14 (37.8%). The 5-year overall survival by was 83% for stage I, 71% for stage II, 60% for stage III, and 44% for stage IV (p=0.0426). Five year progression free survival was 71% for stage I, 62% stage II, 42% stage III, and 37% for stage IV (p=0.0532). In conclusion with the rare thymic tumors early stage and complete resection have the highest impact on overall and progression free survival.

흉선종의 WHO 분류에 따른 예후인자의 임상적 고찰 (Analysis of Prognostic Factors according to WHO Classification for Thymic Epithelial Tumor)

  • 서영준;금동윤;권건영;박창권
    • The Korean Journal of Thoracic and Cardiovascular Surgery
    • /
    • v.37 no.8
    • /
    • pp.684-690
    • /
    • 2004
  • 배경: 원발성 흉선상피세포종(primary thymic epithelial neoplasm)은 다양한 생물학적 및 형태학적인 특성을 가진 종격동 종양이다. 이 연구에서는 59예의 흉선종 환자를 새로운 WHO분류에 따라 재분류하고, Masaoka 임상적 병기를 비롯한 여러 가지 임상적인 특성을 분석함으로써 예후에 영향을 미치는 인자를 알아보고 WHO 분류가 독립적인 예후인자가 될 수 있는지를 알아보고자 했다. 대상 및 방법: 1986년 12월부터 2003년 8월까지 계명대학교 동산의료원에서 흉선종으로 진단 받은 후 수술적 치료를 받은 59예를 대상으로 생존율에 영향을 미치는 예후인자를 흉선종의 조직학적 분류(WHO classification)와 임상적 병기(Masaoka's clinical stage) 및 환자의 특성(성별, 나이, 중증근무력증 유무, 종괴의 크기, 종괴의 침습 유무, 재발, 전이)에 따라 분석하였다. 그리고 조직학적 분류와 임상적 병기사이의 연관성을 분석하였다. 결과: 남자는 32예, 여자는 27예였으며 평균연령은 50.1$\pm$14.2세였다. 모든 흉선종은 WHO 분류에 따라 A부터 C까지 재분류하였다. WHO 분류에 따라 Type A는 6명(10.2%)이었고 AB는 7명(11.9%), B$_1$은 7명(11.9%), B$_2$는 10명(16.9%), B$_3$는 7명(11.9%), C는 22명(37.3%)으로 나타났다. 여러 가지 임상적 특성 가운데 다변수 분석을 통해 완전절제(p=0.033)와 주변조직으로의 저침습성(p=0.001)이 좋은 예후와 연관이 있는 것으로 나타났다. 전체 흉선종의 5년 생존율은 53%였으며 WHO 분류에 따른 5년 생존율은 Type A+AB가 92.3%, B$_1$+B$_2$가 70.2%, B$_3$+C가 26.1%로 나타났다. WHO 조직학적 분류와 생존율 사이의 상관관계분석에서 WHO 조직학적 분류는 예후와 통제적으로 유의하게 연관성이 있는 것으로 나타났다(p<0.001). WHO 분류에 따른 Masaoka 임상병기 분석에서도 두 변수가 통계적으로 유의하게 연관성을 가지는 것으로 나타났다(p<0.001). 결론: WHO 분류는 단순한 조직학적인 분류일 뿐만 아니라 흉선종의 생존율에 중요한 영향을 미치며 종양의 침습성을 잘 반영하는 예후인자임을 알 수 있었다.

흉선에 생긴 carcinoid tumor;1례 보고 (Thymic Carcinoid Tumor - A Case Report -)

  • 김수현;이정철;한승세
    • The Korean Journal of Thoracic and Cardiovascular Surgery
    • /
    • v.25 no.11
    • /
    • pp.1236-1239
    • /
    • 1992
  • Carcinoid tumors arising in the thymus are rare. Since Rosai and Higa in 1972 distinguished these neoplasms from thymomas, fewer than 100 cases have been reported in the world literature. The pathologic diagnosis of thymic carcinoids is been on findings from light microscopy, histochemical studies, and electron microscopy. About 50% of thymic carcinoids are seen with endocrinopathies. Recurrence and extrathoracic metastasis are characteristic of thymic carcinoids. Surgical extirpation of the tumor initially and of the subseguent recurrences in the most effective treatment today The role of adjuvant radiotherapy and chemotherapy is still uncertain. Herein we report a case of thymic carcinoid tumor in a 36-year old male with brief review of literatures.

  • PDF

광범위한 낭성 변화를 보인 고분화성 흉선암종 1예 (A Case of Well-Differentiated Thymic Carcinoma with Extensive Cystic Degeneration)

  • 김경욱;김형중;안철민;이두연;김상진;양우익
    • Tuberculosis and Respiratory Diseases
    • /
    • v.46 no.5
    • /
    • pp.718-722
    • /
    • 1999
  • 14세 여자 환자에서 무증상의 전종격동 낭성 종괴가 있어 절제적 생검을 시행하여 고분화성 흉선암종의 광범위한 낭성 변화로 확진되어 제1기의 흉선종을 완전 적출 후 방사선 치료 혹은 병합화학요법 없이 추후 흉부전산화단층촬영 예정으로 외래에서 경과 관찰 중인 1예를 경험하여 문헌 고찰과 함께 보고하는 바이다.

  • PDF

기도협착을 유발한 흉선낭종 (Thymic Cyst Causing Tracheal Stenosis : one case report)

  • 황정주;양홍석;백효채;홍순원;이두연
    • 대한기관식도과학회지
    • /
    • v.10 no.2
    • /
    • pp.68-71
    • /
    • 2004
  • Thymic cysts are uncommon tumors which usually occur in the neck and mediastinum. It is known to arise from embryonic remnants of the thymopharyngeal duct or from inflammation of thymic tissues. Patients with thymic cyst are often asymptomatic and identified after surgical removal and histologic examination. We experienced a 73 year-old man with recently developed dyspnea. During the examination, chest CT showed a $5\times6cm$ sized cystic mass causing deviation of the trachea. It was located in between the right thyroid gland and anterior mediastinum. It also caused tracheal narrowing noted by bronchoscopy. Right anterior cervical incision and removal of the mass was performed and a histological diagnosis of thymic cyst was confirmed. The patient was discharged without complication.

  • PDF

기도협착을 유발한 흉선낭종 (Thymic Cyst Causing Tracheal Stenosis : one case report)

  • 황정주;양홍석;백효채;홍순원;이두연
    • 대한기관식도과학회지
    • /
    • v.11 no.1
    • /
    • pp.25-27
    • /
    • 2005
  • Thymic cysts are uncommon tumors which usually occur in the neck and mediastinum. It is known to arise from embryonic remnants of the thymopharyngeal duct or from infammation of thymic tissues. Patients with thymic cyst are often asymptomatic and identified after surgical removal and histologic examination. We experienced a 73 year-old man with recently developed dyspnea. During the examination, chest CT showed a $5{\times}6cm$ sized cystic mass causing deviation of the trachea. It was located in between the right thyroid gland and anterior mediastinum. It also caused tracheal narrowing noted by bronchoscopy. Right anterior cervical incision and removal of the mass was performed and a histological diagnosis of thymic cyst was confirmed. The patient was discharged without complication.

  • PDF

흉선 상피 종양의 임상적 고찰 (Clinical Features of Thymic Epithelial Tumors)

  • 목정하;설희윤;김지은;김기욱;박혜경;이호석;김영대;김윤성;이창훈;이민기;박순규
    • Tuberculosis and Respiratory Diseases
    • /
    • v.65 no.1
    • /
    • pp.23-28
    • /
    • 2008
  • 연구배경: 흉선 상피 종양은 전종격동에 발생하는 가장 흔한 종양으로 비특이적인 증상을 나타내는 경우가 많아 진단 및 치료에 어려움이 있다. 본 연구에서는 부산대학교병원에서 진단된 흉선 상피 종양의 임상적 특징을 알아보고자 하였다. 방 법: 1997년 1월에서 2007년 1월까지 흉선 상피 종양 으로 조직학적 진단을 받은 37명의 환자를 대상으로 임상적, 조직학적 소견을 후향적으로 분석하였다. 조직학적 분류는 WHO 분류법, 임상적 병기는 Masaoka 병기분류법을 기초로 하였다. 대상 환자는 총 37명으로 남자가 23명, 여자가 14명이었고, 평균 연령은 51.3세였다. 결 과: 진단시 무증상인 경우가 7명이었고, 증상이 있는 경우가 30명이었으며, 빈도는 흉통(53%), 호흡곤란(23%), 기침(17%) 순이었다. 5명(17%)에서 중증근무력증이 동반되었다. 진단 당시 병기는 stage I (8%), stage II (28%), stage III (32%), stage IVA (16%), stage IVB (16%)의 순으로, stage III 이상인 경우가 64%를 차지하였다. 조직학적 분류의 빈도는 type B1 (32%), C (23%), B3 (20%), B2 (16%), AB (6%), A (3%) 순이었다. 치료를 받은 31명의 환자 중 24명의 환자가 흉선절제술을 시행받았으며, 5명은 항암화학요법 단독치료, 2명은 항암화학요법과 방사선치료를 병행하였다. 흉선절제술을 시행한 24명의 환자 중 4명에서 흉선 상피 종양이 재발하였으며, stage III 및 type B3인 경우가 많았다. 또한 추적관찰 기간 동안 5명의 환자가 사망하였으며, stage IV 및 type B3, C인 경우가 많았다. 결 론: 흉선 상피 종양은 진단시 stage III 이상 또는 조직학적 분류상 type B, C가 많았고 이러한 경우 재발 및 전이의 위험이 높아 불량한 예후와 연관이 있는 것으로 생각된다.